Daily text messaging ups ART adherence in youth

December 20, 2016

(HealthDay)—A two-way, personalized daily text messaging intervention can improve antiretroviral therapy (ART) adherence among HIV-positive adolescents and young adults, according to a study published in AIDS and Behavior.

Robert Garofalo, M.D., M.P.H., from the Ann & Robert H. Lurie Children's Hospital in Chicago, and colleagues conducted a randomized trial of a two-way, personalized daily text messaging to improve ART adherence among 105 poorly adherent HIV-positive adolescents and (age 16 to 29 years). ART adherence was assessed via self-report visual analogue scale at three and six months for mean adherence level and proportion who were ≥90 percent adherent.

The researchers found that over the six-month intervention period, the average effect estimate was significant for ≥90 percent adherence (odds ratio, 2.12) and was maintained six months after intervention (at 12 months). Very high satisfaction scores were seen for the intervention.

"These results suggest both feasibility and initial efficacy of this approach," the authors write. "Given study limitations, additional testing of this intervention as part of a larger clinical trial with objective and/or clinical outcome measures of adherence is warranted."

Explore further: Review: mHealth text messages promote medication adherence

More information: Full Text (subscription or payment may be required)

Related Stories

Sizable proportion of patients nonadherent to glaucoma meds

July 16, 2014

(HealthDay)—A considerable proportion of patients are nonadherent to glaucoma medication, but a telecommunication intervention can improve adherence, according to two studies published in the July issue of JAMA Ophthalmology.

Only half of kidney stone patients compliant with Tx

February 22, 2016

(HealthDay)—Just over half of kidney stone patients are adherent to preventive pharmacological therapy, and adherent patients have lower levels of health care utilization, according to a study published in the March issue ...

Baseline depression symptoms tied to low med adherence

July 18, 2016

(HealthDay)—Among clinical and sociodemographic characteristics, only baseline depressive symptoms are tied to low medication adherence in teen patients with type 2 diabetes, according to a study published online June 28 ...

Recommended for you

Team tests best delivery mode for potential HIV vaccine

June 20, 2017

For decades, HIV has successfully evaded all efforts to create an effective vaccine but researchers at The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) are steadily inching ...

Understanding HIV's persistence

June 19, 2017

Most cells in the human body have a limited lifespan, typically dying after several days or weeks. And yet, HIV-1 infected cells manage to persist in the body for decades. Current treatment for HIV is very effective at suppressing ...

Researchers uncover clues about how HIV virus mutates

June 1, 2017

A new study published in Cell Host & Microbe led by researchers at Fred Hutchinson Cancer Research Center completely maps all mutations that help the HIV virus evolve away from a single broadly neutralizing antibody, known ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.